NeuroPace Inc Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
NeuroPace Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q2 2024.
  • NeuroPace Inc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $2.55M, a 4.03% decline year-over-year.
  • NeuroPace Inc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $9.87M, a 9.16% increase year-over-year.
  • NeuroPace Inc annual Share-based Payment Arrangement, Expense for 2023 was $9.56M, a 14.5% increase from 2022.
  • NeuroPace Inc annual Share-based Payment Arrangement, Expense for 2022 was $8.35M, a 94.7% increase from 2021.
  • NeuroPace Inc annual Share-based Payment Arrangement, Expense for 2021 was $4.29M, a 211% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $9.87M $2.55M -$107K -4.03% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $9.97M $2.54M +$415K +19.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $9.56M $2.36M +$281K +13.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 $9.28M $2.42M +$239K +11% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $9.04M $2.66M +$52K +2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $8.99M $2.13M +$637K +42.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $8.35M $2.08M +$200K +10.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 $8.15M $2.18M +$1.08M +97.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $7.07M $2.6M +$1.5M +136% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $5.57M $1.49M +$1.29M +637% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $4.29M $1.88M +$1.39M +285% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 $2.9M $1.11M +$806K +268% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $2.09M $1.1M +$813K +280% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $1.28M $202K -$99K -32.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $1.38M $487K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 $301K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $290K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $301K Jan 1, 2020 Mar 31, 2020 10-Q 2021-06-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.